Northway Biotech vs Wacker Biotech: CDMO Comparison

Side-by-side comparison of Northway Biotech and Wacker Biotech on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.

Vilnius, LT; Waltham (MA), USA
Signal Score
81/100
Quality (FDA + GMP)
100/100
FDA inspections
0
FDA warning letters
0
EMA GMP certificates (active)
8
MHRA GMP certificates (compliant)
0
Clinical programs (matched)
0
Capacity
Available
Modalities
Biologics, mAbs, Recombinant proteins, pDNA, AAV, Viral vectors, Gene Therapy
Jena, DE · Amsterdam, NL · San Diego, CA
Signal Score
82/100
Quality (FDA + GMP)
100/100
FDA inspections
0
FDA warning letters
0
EMA GMP certificates (active)
13
MHRA GMP certificates (compliant)
0
Clinical programs (matched)
0
Capacity
—
Modalities
Recombinant Protein, Plasmid DNA, mRNA

What to evaluate for Recombinant Proteins programs

Both Northway Biotech and Wacker Biotech qualify as Recombinant Proteins CDMOs. When choosing between them for Recombinant Proteins programs, weigh these four dimensions specifically — each carries through to the side-by-side scorecard above.

Expression host & scale

Microbial hosts (E. coli, P. pastoris) suit non-glycosylated proteins; mammalian (CHO) is the workhorse for glycoproteins. Confirm validated bioreactor scale and the CDMO's experience with your target.

Purification & analytics

Downstream complexity (multiple chromatography steps, refolding for E. coli) drives cost and timeline. Ask about the orthogonal analytics package — purity, identity, potency.

Regulatory readiness

Clean FDA 483 history and EMA/MHRA GMP coverage matter — both are shown above and on each profile.

Capacity & commercial readiness

For programs heading to BLA, evaluate validated commercial scale and any approved-product track record.

See all Recombinant Proteins CDMOs ranked by Signal Score →

Frequently asked: Northway Biotech vs Wacker Biotech

How do Northway Biotech and Wacker Biotech compare on European GMP coverage?

Northway Biotech holds 8 active EMA GMP certificates and 0 MHRA / UK certificates. Wacker Biotech holds 13 active EMA GMP certificates and 0 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.

Which is better for Recombinant Proteins manufacturing — Northway Biotech or Wacker Biotech?

Both Northway Biotech and Wacker Biotech are tagged as Recombinant Proteins CDMOs in our directory, so both are credible options for Recombinant Proteins programs. The most important differentiator for Recombinant Proteins selection is typically expression host & scale: Microbial hosts (E. coli, P. pastoris) suit non-glycosylated proteins; mammalian (CHO) is the workhorse for glycoproteins. Confirm validated bioreactor scale and the CDMO's experience with your target. Review each CDMO's profile and inspection record before shortlisting.

What does the Signal Score gap mean in practice?

Northway Biotech carries a Signal Score of 81/100 and Wacker Biotech carries 82/100 — essentially tied for Wacker Biotech. The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.

How we score CDMOs →  ·  Compare other CDMOs →

Evaluating Northway Biotech and Wacker Biotech for a program?

Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.

Find & compare CDMOs →
Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.